EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

J. S. Smolen; R. Landewé; F. C. Breedveld; M. Dougados; P. Emery; C. Gaujoux-Viala; S. Gorter; R. Knevel; J. Nam; M. Schoels; D. Aletaha; M. Buch; L. Gossec; T. Huizinga; J. W.J.W. Bijlsma; G. Burmester; B. Combe; M. Cutolo; C. Gabay; J. Gomez-Reino; M. Kouloumas; T. K. Kvien; E. Martin-Mola; I. McInnes; K. Pavelka; P. Van Riel; M. Scholte; D. L. Scott; T. Sokka; G. Valesini; R. Van Vollenhoven; K. L. Winthrop; J. Wong; A. Zink; D. Van Der Heijde

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

J. S. Smolen, R. Landewé, F. C. Breedveld, M. Dougados, P. Emery, C. Gaujoux-Viala, S. Gorter, R. Knevel, J. Nam, M. Schoels, D. Aletaha, M. Buch, L. Gossec, T. Huizinga, J. W.J.W. Bijlsma, G. Burmester, B. Combe, M. Cutolo, C. Gabay, J. Gomez-ReinoM. Kouloumas, T. K. Kvien, E. Martin-Mola, I. McInnes, K. Pavelka, P. Van Riel, M. Scholte, D. L. Scott, T. Sokka, G. Valesini, R. Van Vollenhoven, K. L. Winthrop, J. Wong, A. Zink, D. Van Der Heijde

Ophthalmology

Research output: Contribution to journal › Article

Original language	English (US)
Pages (from-to)	5-21
Number of pages	17
Journal	Revmatologiia
Volume	19
Issue number	1
State	Published - Jun 20 2011

ASJC Scopus subject areas

Rheumatology

Cite this

Smolen, J. S., Landewé, R., Breedveld, F. C., Dougados, M., Emery, P., Gaujoux-Viala, C., Gorter, S., Knevel, R., Nam, J., Schoels, M., Aletaha, D., Buch, M., Gossec, L., Huizinga, T., Bijlsma, J. W. J. W., Burmester, G., Combe, B., Cutolo, M., Gabay, C., ... Van Der Heijde, D. (2011). EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Revmatologiia, 19(1), 5-21.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. / Smolen, J. S.; Landewé, R.; Breedveld, F. C.; Dougados, M.; Emery, P.; Gaujoux-Viala, C.; Gorter, S.; Knevel, R.; Nam, J.; Schoels, M.; Aletaha, D.; Buch, M.; Gossec, L.; Huizinga, T.; Bijlsma, J. W.J.W.; Burmester, G.; Combe, B.; Cutolo, M.; Gabay, C.; Gomez-Reino, J.; Kouloumas, M.; Kvien, T. K.; Martin-Mola, E.; McInnes, I.; Pavelka, K.; Van Riel, P.; Scholte, M.; Scott, D. L.; Sokka, T.; Valesini, G.; Van Vollenhoven, R.; Winthrop, K. L.; Wong, J.; Zink, A.; Van Der Heijde, D.

In: Revmatologiia, Vol. 19, No. 1, 20.06.2011, p. 5-21.

Research output: Contribution to journal › Article

Smolen, JS, Landewé, R, Breedveld, FC, Dougados, M, Emery, P, Gaujoux-Viala, C, Gorter, S, Knevel, R, Nam, J, Schoels, M, Aletaha, D, Buch, M, Gossec, L, Huizinga, T, Bijlsma, JWJW, Burmester, G, Combe, B, Cutolo, M, Gabay, C, Gomez-Reino, J, Kouloumas, M, Kvien, TK, Martin-Mola, E, McInnes, I, Pavelka, K, Van Riel, P, Scholte, M, Scott, DL, Sokka, T, Valesini, G, Van Vollenhoven, R, Winthrop, KL, Wong, J, Zink, A & Van Der Heijde, D 2011, 'EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs', Revmatologiia, vol. 19, no. 1, pp. 5-21.

Smolen, J. S. ; Landewé, R. ; Breedveld, F. C. ; Dougados, M. ; Emery, P. ; Gaujoux-Viala, C. ; Gorter, S. ; Knevel, R. ; Nam, J. ; Schoels, M. ; Aletaha, D. ; Buch, M. ; Gossec, L. ; Huizinga, T. ; Bijlsma, J. W.J.W. ; Burmester, G. ; Combe, B. ; Cutolo, M. ; Gabay, C. ; Gomez-Reino, J. ; Kouloumas, M. ; Kvien, T. K. ; Martin-Mola, E. ; McInnes, I. ; Pavelka, K. ; Van Riel, P. ; Scholte, M. ; Scott, D. L. ; Sokka, T. ; Valesini, G. ; Van Vollenhoven, R. ; Winthrop, K. L. ; Wong, J. ; Zink, A. ; Van Der Heijde, D. / EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. In: Revmatologiia. 2011 ; Vol. 19, No. 1. pp. 5-21.

@article{4b5bae9dfded471d8b1a0a38ae110ca8,

title = "EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs",

author = "Smolen, {J. S.} and R. Landew{\'e} and Breedveld, {F. C.} and M. Dougados and P. Emery and C. Gaujoux-Viala and S. Gorter and R. Knevel and J. Nam and M. Schoels and D. Aletaha and M. Buch and L. Gossec and T. Huizinga and Bijlsma, {J. W.J.W.} and G. Burmester and B. Combe and M. Cutolo and C. Gabay and J. Gomez-Reino and M. Kouloumas and Kvien, {T. K.} and E. Martin-Mola and I. McInnes and K. Pavelka and {Van Riel}, P. and M. Scholte and Scott, {D. L.} and T. Sokka and G. Valesini and {Van Vollenhoven}, R. and Winthrop, {K. L.} and J. Wong and A. Zink and {Van Der Heijde}, D.",

year = "2011",

month = jun

day = "20",

language = "English (US)",

volume = "19",

pages = "5--21",

journal = "Revmatologiia (Bulgaria)",

issn = "1310-0505",

publisher = "Meditsiinski Unversitet-Sofia",

number = "1",

}

TY - JOUR

T1 - EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

AU - Smolen, J. S.

AU - Landewé, R.

AU - Breedveld, F. C.

AU - Dougados, M.

AU - Emery, P.

AU - Gaujoux-Viala, C.

AU - Gorter, S.

AU - Knevel, R.

AU - Nam, J.

AU - Schoels, M.

AU - Aletaha, D.

AU - Buch, M.

AU - Gossec, L.

AU - Huizinga, T.

AU - Bijlsma, J. W.J.W.

AU - Burmester, G.

AU - Combe, B.

AU - Cutolo, M.

AU - Gabay, C.

AU - Gomez-Reino, J.

AU - Kouloumas, M.

AU - Kvien, T. K.

AU - Martin-Mola, E.

AU - McInnes, I.

AU - Pavelka, K.

AU - Van Riel, P.

AU - Scholte, M.

AU - Scott, D. L.

AU - Sokka, T.

AU - Valesini, G.

AU - Van Vollenhoven, R.

AU - Winthrop, K. L.

AU - Wong, J.

AU - Zink, A.

AU - Van Der Heijde, D.

PY - 2011/6/20

Y1 - 2011/6/20

UR - http://www.scopus.com/inward/record.url?scp=79958812251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958812251&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:79958812251

VL - 19

SP - 5

EP - 21

JO - Revmatologiia (Bulgaria)

JF - Revmatologiia (Bulgaria)

SN - 1310-0505

IS - 1

ER -

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

ASJC Scopus subject areas

Cite this

Access to Document